Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation

Lung Cancer

Volumn 62, Issue 3, 2008, Pages 351-355

  Kozak, Kevin R ^a   Hong, Theodore S ^a   Sluss, Patrick M ^a   Lewandrowski, Elizabeth L ^a   Aleryani, Samir L ^a   MacDonald, Shannon M ^a   Choi, Noah C ^a   Yock, Torunn I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

BNP; Cardiotoxicity; CK MB; Lung cancer; Radiation; Troponin

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; TROPONIN T;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DOSIMETRY; FEMALE; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; THORAX CANCER; THORAX RADIOGRAPHY; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; CREATINE KINASE, MB FORM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SMALL CELL LUNG CARCINOMA; THYMUS NEOPLASMS; TROPONIN T;

EID: 56949085426     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.03.024     Document Type: Article

References (20)

1. Carver J.R., Shapiro C.L., Ng A., Jacobs L., Schwartz C., Virgo K.S., et al. Vaughn DJ for the ASCO cancer survivorship expert panel. American society of clinical oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 25 (2007) 3991-4008
2. Adams M.J., Lipsitz S.R., Colan S.D., Tarbell N.J., Treves S.T., Diller L., et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 22 (2004) 3139-3148
3. Heidenreich P.A., Schnittger I., Strauss H.W., Vagelos R.H., Lee B.K., Mariscal C.S., et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 25 (2007) 43-49
4. Marks L.B., Yu X., Prosnitz R.G., Zhou S.-M., Hardenbergh P.H., Blazing M., et al. The incidence and functional consequences of RT-associated cardiac perfusion deficits. Int J Radiat Oncol Biol Phys 63 (2005) 214-223
5. Patt D.A., Goodwin J.S., Kuo Y.-F., Freeman J.L., Zhang D.D., Buchholz T.A., et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol 23 (2005) 7475-7482
6. Giordano S.H., Kuo Y.F., Freeman J.L., Buchholz T.A., Hortobagyi G.N., and Goodwin J.S. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97 (2005) 419-424
7. Darby S.C., McGale P., Taylor C.W., and Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300, 000 women in US SEER cancer registries. Lancet Oncol 6 (2005) 557-565
8. Ak G., Metintas M., Metintas S., Yildirim H., Erginel S., and Alatas F. Lung cancer in individuals less than 50 years of age. Lung 185 (2007) 279-286
9. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined-a consensus document of the Joint European Society for Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36 (2000) 959-969
10. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. McCullough PA for the breathing not properly multinational study investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New Engl J Med 347 (2002) 161-167
11. Januzzi J.L., Camargo C.A., Anwaruddin S., Baggish A.L., Chen A.A., Krauser D.G., et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 95 (2005) 948-954
12. Dautzenberg B., Arriagada R., Chammard A.B., Jarema A., Mezzetti M., Mattson K., et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques. Cancer 86 (1999) 265-273
13. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials. PORT Meta-analysis Trialists Group. Lancet 1998; 352:257-263.
14. Mukherjee S., Aston D., Minett M., Brewster A.E., and Crosby T.D. The significance of cardiac doses received during chemoradiation of oesophageal and gastro-oesophageal junctional cancers. Clin Oncol (R Coll Radiol) 15 (2003) 115-120
15. Bryant J., Picot J., Baxter L., Levitt G., Sullivan I., and Clegg A. Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review. Eur J Cancer 43 (2007) 1959-1966
16. Urbanova D., Urban L., Carter A., Maasova D., and Mladosievicova B. Cardiac troponins-biochemical markers of cardiac toxicity after cytostatic therapy. Neoplasma 53 (2006) 183-190
17. Lipshultz S.E., Rifai N., Dalton V.M., Levy D.E., Silverman L.B., Lipsitz S.R., et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. New Engl J Med 351 (2004) 145-153
18. Cardinale D., Colombo A., Sandri M.T., Lamantia G., Colombo N., Civelli M., et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation 114 (2006) 2474-2481
19. Hughes-Davies L., Sacks D., Rescigno J., Howard S., and Harris J. Serum cardiac troponin T levels during treatment of early-stage breast cancer. J Clin Oncol 13 (1995) 2582-2584
20. Gyenes G., Gagliardi G., Lax I., Fornander T., and Rutqvist L.E. Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol 15 (1997) 1348-1353